Effects of atorvastatin and rosuvastatin on renal function in patients at high cardiovascular risk: a meta-analysis of 21 randomized trials

被引：0
|
作者：
Savarese, G. [1 ]
Volpe, M. [2 ]
Musella, F. [1 ]
Casaretti, L. [1 ]
Perrone-Filardi, P. [1 ]
机构：
[1] Univ Naples Federico II, Dpt Clin Med Cardiovasc & Immunol Sci, Naples, Italy
[2] Univ Roma La Sapienza, Dept Clin & Mol Med, Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：950 / 950
页数：1
相关论文
共 50 条
  • [21] Effects of phytosterols on cardiovascular risk factors: A systematic review and meta-analysis of randomized controlled trials
    Yang, Yanhong
    Xia, Jiayue
    Yu, Tingqing
    Wan, Shiyun
    Zhou, Yajie
    Sun, Guiju
    PHYTOTHERAPY RESEARCH, 2025, 39 (01) : 3 - 24
  • [22] Comparison of Benefits and Risks of Rosuvastatin Versus Atorvastatin from a Meta-Analysis of Head-to-Head Randomized Controlled Trials
    Wlodarczyk, John
    Sullivan, David
    Smith, Michael
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (12): : 1654 - 1662
  • [23] A meta-analysis of randomized head-to-head trials of atorvastatin versus rosuvastatin for reductions in C-reactive protein
    Takagi, Hisato
    Umemoto, Takuya
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 154 (01) : 78 - 81
  • [24] A meta-analysis of randomized trials for effects of periprocedural atorvastatin on contrast-induced nephropathy
    Takagi, Hisato
    Umemoto, Takuya
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 153 (03) : 323 - 325
  • [25] Effects of atorvastatin on carotid intima media thickness: a meta-analysis of randomized controlled trials
    Takagi, Hisato
    Yamamoto, Hirotaka
    Iwata, Kotaro
    Goto, Shin-nosuke
    Umemoto, Takuya
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 159 (01) : 69 - 72
  • [26] Effects of Atorvastatin and Rosuvastatin on Renal Function in Patients With Type 2 Diabetes Mellitus
    Lai, Chao-Lun
    Chou, Hsu-Wen
    Chan, K. Arnold
    Lai, Mei-Shu
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (05): : 619 - 624
  • [27] Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials
    Kristian B Filion
    Fouad El Khoury
    Michael Bielinski
    Ian Schiller
    Nandini Dendukuri
    James M Brophy
    BMC Cardiovascular Disorders, 10
  • [28] Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials
    Filion, Kristian B.
    El Khoury, Fouad
    Bielinski, Michael
    Schiller, Ian
    Dendukuri, Nandini
    Brophy, James M.
    BMC CARDIOVASCULAR DISORDERS, 2010, 10
  • [29] COST-EFFECTIVENESS ANALYSIS OF ROSUVASTATIN VERSUS GENERIC ATORVASTATIN IN PATIENTS AT HIGH CARDIOVASCULAR RISK IN SPAIN
    Brosa, M.
    Barrios, V
    Lobos, J. M.
    Serrano, A.
    Capel, M.
    Alvarez, C.
    VALUE IN HEALTH, 2011, 14 (07) : A380 - A380
  • [30] Assessment and quantification of the benefit risk ratio of rosuvastatin and atorvastatin from a meta-analysis of head to head randomised controlled trials
    Wlodarczyk, J. H.
    Smith, M.
    Sullivan, D. R.
    VALUE IN HEALTH, 2008, 11 (03) : A188 - A189
12345